Correlation Between Vertex Pharmaceutic and Regeneron Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceutic and Regeneron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceutic and Regeneron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceutic and Regeneron Pharmaceuticals, you can compare the effects of market volatilities on Vertex Pharmaceutic and Regeneron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceutic with a short position of Regeneron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceutic and Regeneron Pharmaceuticals.

Diversification Opportunities for Vertex Pharmaceutic and Regeneron Pharmaceuticals

0.4
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Vertex and Regeneron is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceutic and Regeneron Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regeneron Pharmaceuticals and Vertex Pharmaceutic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceutic are associated (or correlated) with Regeneron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regeneron Pharmaceuticals has no effect on the direction of Vertex Pharmaceutic i.e., Vertex Pharmaceutic and Regeneron Pharmaceuticals go up and down completely randomly.

Pair Corralation between Vertex Pharmaceutic and Regeneron Pharmaceuticals

Given the investment horizon of 90 days Vertex Pharmaceutic is expected to generate 1.16 times more return on investment than Regeneron Pharmaceuticals. However, Vertex Pharmaceutic is 1.16 times more volatile than Regeneron Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Regeneron Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest  27,005  in Vertex Pharmaceutic on April 3, 2022 and sell it today you would earn a total of  1,727  from holding Vertex Pharmaceutic or generate 6.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vertex Pharmaceutic  vs.  Regeneron Pharmaceuticals

 Performance (%) 
      Timeline 
Vertex Pharmaceutic 
Vertex Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceutic are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Vertex Pharmaceutic may actually be approaching a critical reversion point that can send shares even higher in August 2022.

Structure and Payout Changes

Last Split Factor
2:1
Last Split Date
2000-08-24

Vertex Price Channel

Regeneron Pharmaceuticals 
Regeneron Performance
0 of 100
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in August 2022. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Regeneron Price Channel

Vertex Pharmaceutic and Regeneron Pharmaceuticals Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Vertex Pharmaceutic and Regeneron Pharmaceuticals

The main advantage of trading using opposite Vertex Pharmaceutic and Regeneron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceutic position performs unexpectedly, Regeneron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regeneron Pharmaceuticals will offset losses from the drop in Regeneron Pharmaceuticals' long position.
The idea behind Vertex Pharmaceutic and Regeneron Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go